Your browser doesn't support javascript.
loading
Preparation of astaxanthin/zeaxanthin-loaded nanostructured lipid carriers for enhanced bioavailability: Characterization-, stability-and permeability study.
Radic, Kristina; Barbosa, Ana Isabel; Reis, Salette; Marijan, Marijan; Lima, Sofia Antunes Costa; Cepo, Dubravka Vitali.
Affiliation
  • Radic K; 1University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Food Chemistry 10000 Zagreb, Croatia.
  • Barbosa AI; 2LAQV, REQUIMTE, Departamento de Ciências Químicas, University of Porto, 4050-313 Porto, Portugal.
  • Reis S; 2LAQV, REQUIMTE, Departamento de Ciências Químicas, University of Porto, 4050-313 Porto, Portugal.
  • Marijan M; 3University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmacognosy 10000 Zagreb Croatia.
  • Lima SAC; 4LAQV, REQUIMTE, Instituto de Ciências Biomédicas de Abel Salazar University of Porto, 4050-313 Porto Portugal.
  • Cepo DV; 1University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Food Chemistry 10000 Zagreb, Croatia.
Acta Pharm ; 73(4): 581-599, 2023 Dec 01.
Article in En | MEDLINE | ID: mdl-38147480
ABSTRACT
Astaxanthin (ASTA) and zeaxanthin (ZEA) are xanthophyll carotenoids showing a wide spectrum of health-promoting properties. However, their utilization is limited, mostly due to poor water solubility, limited bioavailability, and a tendency to oxidate, as well as photo- and thermal instability. The aim of this work was to develop ASTA- and ZEA-loaded nano-structured lipid carriers (NLCs) that would protect them against degradation and improve their intestinal stability/permeability. Obtained NLCs were characterized by an effective diameter of 294 nm for ASTA-NLC and 280 nm for ZEA-NLC; polydispersity index (PDI) lower than 0.2; and zeta potential of -29.4 mV and -29.0 mV, respectively. Interestingly, despite similar physicochemical characteristics, our investigation revealed differences in the encapsulation efficiency of ASTA-NLC and ZEA-NLC (58.0 % vs. 75.5 %, respectively). Obtained NLCs were stable during a 21 day-storage period in the dark at room temperature or at 4 °C. Investigation of gastrointestinal stability showed no change in effective diameter and PDI under gastric conditions while both parameters significantly changed under intestinal conditions. Our results showed for the first time that both ASTA- and ZEA-NLCs intestinal absorption investigated in the in vitro model is significantly increased (in relation to pure compounds) and is affected by the presence of mucus. This study provides useful data about the advantages of using NLC as a delivery system for ASTA and ZEA that might facilitate their applications in the food and pharmaceutical industry.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Carriers / Nanostructures Language: En Journal: Acta Pharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Carriers / Nanostructures Language: En Journal: Acta Pharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: